Search Ontology:
ChEBI

NS 1619

Term ID
CHEBI:34879
Synonyms
  • 1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one
  • 1-(2'-hydroxy-5'-trifluoromethylphenyl)-5-trifluoromethyl-2(3H)-benzimidazolone
  • 1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-1,3-dihydro-2H-benzimidazol-2-one
  • 5-trifluoromethyl-2,3-dihydro-1-(5-trifluoromethyl-2-hydroxyphenyl)-1H-2-oxo-benzimidazole
  • NS-1619
  • NS1619
Definition
A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one in which the hydrogens at positions 1 and 5 are replaced are replaced by 2-hydroxy-5-(trifluoromethyl)phenyl and trifluoromethyl groups, respectively. It is an opener/activator of the large-conductance calcium-activated potassium channel (Bkca).
References
  • cas:153587-01-0
  • kegg.compound:C13833
  • lincs.smallmolecule:LSM-3206
  • pubmed:15543339
  • pubmed:18706395
  • pubmed:21415309
  • pubmed:21441626
  • pubmed:24398773
  • pubmed:24497961
  • pubmed:24813114
  • pubmed:7534190
  • pubmed:7589189
  • pubmed:9151934
  • reaxys:8165035
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from NS 1619
Phenotype where environments contain NS 1619
Phenotype modified by environments containing NS 1619
Phenotype affecting NS 1619
Human Disease Model